<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04645264</url>
  </required_header>
  <id_info>
    <org_study_id>18080302</org_study_id>
    <nct_id>NCT04645264</nct_id>
  </id_info>
  <brief_title>Effect of Catheter on Postoperative Urinary Retention</brief_title>
  <official_title>Effect of Indwelling Foley Placement, Immediate Post-Operative Straight Catheterization, or No Catheterization on Post-operative Urinary Retention After Transforaminal Lumbar Interbody Fusions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rush University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rush University Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine if indwelling Foley placement at the onset of the procedure, straight&#xD;
      catherization at the conclusion of the procedure, or no catheterization produces the lowest&#xD;
      rates of postoperative urinary retention after transforaminal lumbar interbody fusions&#xD;
      (TLIFs).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Post-operative urinary retention (POUR) is one the most common post-operative complications&#xD;
      after elective spine surgeries. Common causes of postoperative urinary retention (POUR)&#xD;
      include bladder stenosis, distension, trauma due to catheterizations, age, and prostate&#xD;
      hyperplasia. The incidence of POUR increases with age, gender, types of surgery conducted,&#xD;
      any comorbidities such as cerebral palsy or multiple sclerosis, use of drugs such as&#xD;
      anticholinergic agents, beta blockers, or sympathomimetics, and use of IV fluids.&#xD;
&#xD;
      This condition has been associated with the development of UTIs and sepsis, increased&#xD;
      post-operative length of stay (LOS), and 90-day readmission after surgery. In the field of&#xD;
      spine surgery, the reported incidence of POUR is highly variable, and there is no consensus&#xD;
      on effective methods of prevention. We set out to assess POUR from patients catheterized&#xD;
      compared to non-catheterized following a transforaminal lumbar interbody fusion.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    PI initiated closure due to limited clinical resources and lack of participation.&#xD;
  </why_stopped>
  <start_date type="Actual">September 26, 2018</start_date>
  <completion_date type="Actual">July 10, 2019</completion_date>
  <primary_completion_date type="Actual">July 10, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Spontaneous urination</measure>
    <time_frame>From date of surgery until the date of hospital discharge, up to 1 month postoperatively</time_frame>
    <description>If patient has the ability to spontaneously urinate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post-void bladder scan</measure>
    <time_frame>From date of surgery until the date of hospital discharge, up to 1 month postoperatively</time_frame>
    <description>Post-void bladder volume obtained from ultrasound bladder scan</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Need for straight catheterization or post-operative indwelling Foley catheter placement</measure>
    <time_frame>From date of surgery until the date of hospital discharge, up to 1 month postoperatively</time_frame>
    <description>Did patient need straight catheterization due to urinary retention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Initiation of an alpha-1 inhibitor post-operatively</measure>
    <time_frame>From date of surgery until the date of hospital discharge, up to 1 month postoperatively</time_frame>
    <description>Did patient receive an alpha-1 inhibitor post-operatively?</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Urologic consultations for evaluation of post-operative urinary complications</measure>
    <time_frame>From date of surgery until the date of hospital discharge, up to 1 month postoperatively</time_frame>
    <description>Did patient have a urology consultation?</description>
  </primary_outcome>
  <primary_outcome>
    <measure>UTI acquired post-operatively</measure>
    <time_frame>6 weeks</time_frame>
    <description>Did the patient acquire a urinary tract infection?</description>
  </primary_outcome>
  <primary_outcome>
    <measure>UTI acquired post-operatively</measure>
    <time_frame>12 weeks</time_frame>
    <description>Did the patient acquire a urinary tract infection?</description>
  </primary_outcome>
  <primary_outcome>
    <measure>UTI acquired post-operatively</measure>
    <time_frame>6 month</time_frame>
    <description>Did the patient acquire a urinary tract infection?</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>From date of surgery until the date of hospital discharge, up to 1 month postoperatively</time_frame>
    <description>How long was the patients post-operative stay?</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">7</enrollment>
  <condition>Transforaminal Lumbar Interbody Fusion</condition>
  <arm_group>
    <arm_group_label>Indwelling Foley</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Indwelling Foley placed during surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Straight Catheter</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>straight catheterization (in-and-out straight catheterization) will take place at the end of the surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Catheter</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patient is not catheterized</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Foley Catheter</intervention_name>
    <description>The patient is catheterized during surgery.</description>
    <arm_group_label>Indwelling Foley</arm_group_label>
    <arm_group_label>Straight Catheter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing a primary single-level MIS TLIF (Diagnosis: radiculopathy,&#xD;
             stenosis, herniated nucleus pulposus, degenerative disc disease, spondylosis,&#xD;
             osteophytic complexes, spondylolysis, spondylolisthesis)&#xD;
&#xD;
          -  Patients able to provide informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with baseline urinary dysfunction requiring manual bladder emptying via&#xD;
             intermittent straight catheterization, suprapubic catheters, or other indwelling&#xD;
             catheters. -Allergies or other contraindications to medicines in the post- operative&#xD;
             urinary retention protocol&#xD;
&#xD;
          -  Lack of consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 6, 2019</study_first_submitted>
  <study_first_submitted_qc>November 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 27, 2020</study_first_posted>
  <last_update_submitted>October 21, 2021</last_update_submitted>
  <last_update_submitted_qc>October 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rush University Medical Center</investigator_affiliation>
    <investigator_full_name>Carla Edwards</investigator_full_name>
    <investigator_title>Clinical Research Manger</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Retention</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 12, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/64/NCT04645264/Prot_SAP_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>May 12, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/64/NCT04645264/ICF_002.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

